Novel PET tracers: added value for endocrine disorders

被引:18
作者
Bergeret, Sebastien [1 ]
Charbit, Judith [1 ]
Ansquer, Catherine [2 ,3 ]
Bera, Geraldine [1 ,4 ]
Chanson, Philippe [5 ,6 ]
Lussey-Lepoutre, Charlotte [1 ,7 ]
机构
[1] Sorbonne Univ, Nucl Med Dept, Pitie Salpetriere Hosp, 47-83 Bd Hop, F-75013 Paris, France
[2] CHU Hotel Dieu, Nucl Med Dept, 1 Pl Alexis Ricordeau, F-44093 Nantes 1, France
[3] Angers Univ, CIRCINA INSERM, 8 Quai Moncousu, F-44000 Nantes, France
[4] Sorbonne Univ, LIB, INSERM U1146, Paris, France
[5] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Ctr Reference Malad Rares Hypophyse, F-94275 Le Kremlin Bicetre, France
[6] Univ Paris Saclay, Univ Paris Sud, Fac Med Paris Sud, INSERM UMR S1185, F-94276 Le Kremlin Bicetre, France
[7] Georges Pompidou European Hosp, Cardiovasc Res Ctr, INSERM U970, 56 Rue Leblanc, F-75015 Paris, France
关键词
PET/CT; Neuroendocrine tumors; Primary hyperparathyroidism; 18F-Choline; 18F-FDOPA; Gallium-68; Somatostatin; 18F-FDG; POSITRON-EMISSION-TOMOGRAPHY; MEDULLARY-THYROID CARCINOMA; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS; FUNCTIONAL IMAGING MODALITIES; PRIMARY HYPERPARATHYROIDISM; F-18-DOPA PET; GA-68-DOTATATE PET/CT; PREOPERATIVE LOCALIZATION; PROGNOSTIC VALUE;
D O I
10.1007/s12020-019-01895-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nuclear medicine has been implicated in the diagnosis and treatment of endocrine disorders for several decades. With recent development of PET tracers, functional imaging now plays a major role in endocrine tumors enabling with high performance to their localization, characterization, and staging. Besides F-18-FDG, which may be used in the management and follow-up of endocrine tumors, new tracers have emerged, such as F-18-DOPA for neuroendocrine tumors (NETs) (medullary thyroid carcinoma, pheochromocytomas and paragangliomas and well-differentiated NETs originating from the midgut) and F-18-Choline in the field of primary hyperparathyroidism. Moreover, some peptides such as somatostatin analogs can also be used for peptide receptor radionuclide therapy. In this context, Gallium-68 labeled somatostatin analogs (Ga-68-SSA) can help to tailor therapeutic choices and follow the response to treatment in the so-called theranostic approach. This review emphasizes the usefulness of these three novel PET tracers (F-18-Choline, F-18-FDOPA, and Ga-68-SSA) for primary hyperparathyroidism and neuroendocrine tumors.
引用
收藏
页码:14 / 30
页数:17
相关论文
共 135 条
[61]   Premedication With Carbidopa Masks Positive Finding of Insulinoma and β-Cell Hyperplasia in [18F]-Dihydroxy-Phenyl-Alanine Positron Emission Tomography [J].
Kauhanen, Saila ;
Seppanen, Marko ;
Nuutila, Pirjo .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (32) :5307-5308
[62]   Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer [J].
Kauhanen, Saila ;
Schalin-Jantti, Camilla ;
Seppanen, Marko ;
Kajander, Sami ;
Virtanen, Sami ;
Schildt, Jukka ;
Lisinen, Irina ;
Ahonen, Aapo ;
Heiskanen, Ilkka ;
Vaisanen, Mika ;
Arola, Johanna ;
Korsoff, Pirkko ;
Ebeling, Tapani ;
Sane, Timo ;
Minn, Heikki ;
Valimaki, Matti J. ;
Nuutila, Pirjo .
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (12) :1855-1863
[63]   A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors [J].
Kayani, Irfan ;
Conry, Brendon G. ;
Groves, Ashley M. ;
Win, Thida ;
Dickson, John ;
Caplin, Martyn ;
Bomanji, Jamshed B. .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (12) :1927-1932
[64]   Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus [J].
Khan, A. A. ;
Hanley, D. A. ;
Rizzoli, R. ;
Bollerslev, J. ;
Young, J. E. M. ;
Rejnmark, L. ;
Thakker, R. ;
D'Amour, P. ;
Paul, T. ;
Van Uum, S. ;
Shrayyef, M. Zakaria ;
Goltzman, D. ;
Kaiser, S. ;
Cusano, N. E. ;
Bouillon, R. ;
Mosekilde, L. ;
Kung, A. W. ;
Rao, S. D. ;
Bhadada, S. K. ;
Clarke, B. L. ;
Liu, J. ;
Duh, Q. ;
Lewiecki, E. Michael ;
Bandeira, F. ;
Eastell, R. ;
Marcocci, C. ;
Silverberg, S. J. ;
Udelsman, R. ;
Davison, K. Shawn ;
Potts, J. T., Jr. ;
Brandi, M. L. ;
Bilezikian, J. P. .
OSTEOPOROSIS INTERNATIONAL, 2017, 28 (01) :1-19
[65]   Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications [J].
Kloeppel, Guenter .
VISCERAL MEDICINE, 2017, 33 (05) :324-330
[66]   Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association [J].
Kloos, Richard T. ;
Eng, Charis ;
Evans, Douglas B. ;
Francis, Gary L. ;
Gagel, Robert F. ;
Gharib, Hossein ;
Moley, Jeffrey F. ;
Pacini, Furio ;
Ringel, Matthew D. ;
Schlumberger, Martin ;
Wells, Samuel A., Jr. .
THYROID, 2009, 19 (06) :565-612
[67]   18F Fluorocholine PET/MR Imaging in Patients with Primary Hyperparathyroidism and Inconclusive Conventional Imaging: A Prospective Pilot Study [J].
Kluijfhout, Wouter P. ;
Pasternak, Jesse D. ;
Gosnell, Jessica E. ;
Shen, Wen T. ;
Duh, Quan-Yang ;
Vriens, Menno R. ;
de Keizer, Bart ;
Hope, Thomas A. ;
Glastonbury, Christine M. ;
Pampaloni, Miguel H. ;
Suh, Insoo .
RADIOLOGY, 2017, 284 (02) :460-467
[68]   Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands [J].
Kluijfhout, Wouter P. ;
Vorselaars, Wessel M. C. M. ;
van den Berk, Sandra A. M. ;
Vriens, Menno R. ;
Rinkes, Inne H. M. Borel ;
Valk, Gerlof D. ;
van Dalen, Thijs ;
de Klerk, John M. H. ;
de Keizer, Bart .
NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (12) :1246-1252
[69]   18F-Dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer:: Relation to tumor differentiation [J].
Koopmans, Klaas P. ;
de Groot, Jan Willem B. ;
Plukker, John T. M. ;
de Vries, Elisabeth G. E. ;
Kema, Ido P. ;
Sluiter, Wim J. ;
Jager, Pieter L. ;
Links, Thera P. .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (04) :524-531
[70]   Staging of carcinoid tumours with 18F-DOPA PET:: a prospective, diagnostic accuracy study [J].
Koopmans, Klaas P. ;
de Vries, Elisabeth G. E. ;
Kerna, Ido P. ;
Elsinga, Philip H. ;
Neels, Oliver C. ;
Sluiter, Wim J. ;
van der Horst-Schrivers, Anouk N. A. ;
Jager, Pieter L. .
LANCET ONCOLOGY, 2006, 7 (09) :728-734